PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
4.430
-0.150 (-3.28%)
At close: Apr 28, 2026, 4:00 PM EDT
4.610
+0.180 (4.06%)
After-hours: Apr 28, 2026, 4:18 PM EDT
PolyPid Employees
As of December 31, 2025, PolyPid had 75 total employees, including 69 full-time and 6 part-time employees. The number of employees increased by 14 or 22.95% compared to the previous year.
Employees
75
Change (1Y)
14
Growth (1Y)
22.95%
Revenue / Employee
n/a
Profits / Employee
-$455,587
Market Cap
84.54M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Gossamer Bio | 162 |
| Sangamo Therapeutics | 142 |
| Adicet Bio | 102 |
| Pelthos Therapeutics | 92 |
| Rani Therapeutics Holdings | 71 |
| eXoZymes | 32 |
| Q32 Bio | 24 |
PYPD News
- 14 hours ago - PolyPid to Present Data from SHIELD II Phase 3 Trial Demonstrating Reduced Severity of Surgical Site Infection at Surgical Infection Society 2026 Annual Meeting - GlobeNewsWire
- 15 days ago - PolyPid to Present New Phase 3 SHIELD II Data Demonstrating D-PLEX₁₀₀ Sustained Local Release at ESCMID Global 2026 - GlobeNewsWire
- 4 weeks ago - PolyPid Initiates D-PLEX₁₀₀ NDA Submission to the FDA - GlobeNewsWire
- 6 weeks ago - PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX₁₀₀'s New Drug Application - GlobeNewsWire
- 7 weeks ago - PolyPid Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 2 months ago - PolyPid Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - PolyPid Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results - GlobeNewsWire